EFFECTS OF β-CAROTENE AND PORPHYRIDIUM CRUENTUM POLYSACCHARIDE EXTRACT ON MITOMYCIN C SENSITIVITY OF BLOOD LYMPHOCYTE CHROMOSOMES OF RADIOLOGY TECHNICIANS
Senol S1,2, Pehlivan M3, Ozdemir G1, Conk-Dalay M4, Kucuk O5, Pehlivan S1,6*
*Corresponding Author: Sacide Pehlivan, PhD., Genetic Diseases Research and Application Center, Ege University, 35100, Izmir, Turkey; Tel.: +90-232-388-0110/2856; Fax: +90-232-388-1036; E-mail: psacide@ hotmail.com, pehlivan@gantep.edu.tr
page: 63

MATERIAL AND METHODS

Porphyridum cruentum (Ege-MACC 09) was obtained from the microalgae culture collection of Ege University (Ege-MACC). The culture medium was F/2 prepared in sea water. The pH was adjusted to 7.5 after the medium was sterilized by autoclaving. Exponentially growing cells were used for the inoculum. The microalgae were grown in a 5 L bio-reactor continuously illuminated at a light intensity of 80 μmol photon m–2 s–1 with fluorescent cool-white lamps. The culture temperature was controlled at  23° C. The vessel was aerated at 1.5 L/min. The aeration gas was filter sterilized by passing through a 0.22 μm mili­pore membrane filter. At the late exponential phase of growth (after ~16-21 days), the cells were separated by centrifugation (104 rpm, 20 min.). The supernatant contain­ing the extracellular polysaccharides was collected and lyophilized. The lyophilized exopolysaccharide was dis­persed in bidistilled water or in an appropriate salt solution by prolonged gentle stirring using a magnetic stirrer under ambient conditions [14].

      After the appropriate institutional ethics committee and informed consent procedures had been completed, we obtained blood samples from five subjects (one female and four males who were between 20 and 35 years of age) who had worked as radiology technicians for at least 5 years and been exposed to low dose radiation (0.05 Sievert/ year). Blood lymphocytes (PBL) were isolated by phycol-hypaque separation and cultured at 37° C in 5 mL of cul­ture medium containing 100 U/mL penicillin, 100 mcg/mL streptomycin (KO3-031-1B; Biological Industries, Jerusa­lem, Israel), 1200 mM L-glutamine (K 0283; Biochrome AG, Berlin, Germany), 1.5% Phytohemagglutinin (M5030; Biochrome AG) and 20% fetal calf serum in basic medium RPMI 1640 (01-106 1B; Biological Industries). Mitomy­cinC (10–7 M) (827 BIC; Kyowa, Tokyo, Japan), βC (10–5 M; Sigma Chemicals, Chicago, IL, USA), PC (0.015 μg/ mL and 0.0037 μg/mL), βC + PC were added to the cul­tures at the end of 48 hours. Mitosis was terminated by adding 0.1 μg/mL of Colchicine (L6211; Biochrom AG) 20 hours later. The cells were then kept at 37°C for 30 min. when 0.075 M hypotonic KCl solution was added and the cells were fixed in freshly prepared cold methanol:glacial acetic acid (3:1) solution. The metaphase preparations were stained by GTG-banding/Giemsa stain and evaluated for numeric and structural aberrations according to ISCN-1989 [15-17].

      Statistical analysis was performed using SPSS for Windows (Version 8.0). Comparisons among each culture were performed using non parametric tests (Student’s t Test). The level of critical significance was p <0.05.

 




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006